Iveric Bio Completes Patient Enrollment of GATHER2 Pivotal Clinical Trial of Zimura® Ahead of Schedule
NEW YORK--(BUSINESS WIRE)--Iveric Bio announced the early completion of patient enrollment of GATHER2, the Company’s 2nd pivotal clinical trial of Zimura® (avacincaptad pegol).